ANTI-TRKA ANTIBODIES WITH ENHANCED INHIBITORY PROPERTIES AND DERIVATIVES THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15265331

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to antibodies directed against TrkA receptor and their uses, including humanized anti-TrkA antibodies. More specifically, the present invention relates to humanized anti-TrkA antibodies with enhanced inhibitory properties comprising a heavy chain variable region, a light chain variable region, a human light chain constant region and a variant human IgG4 heavy chain constant region which exhibit altered exchange properties.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GLENMARK PHARMACEUTICALS S A2300 LA CHAUX-DE-FONDS

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BLEIN, Stanislas La Chaux-de-Fonds, CH 34 432
Ollier, Romain La Chaux-de-Fonds, CH 16 140
Skegro, Darko La Chaux-de-Fonds, CH 34 332

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation